Stephanie Price
Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".
Stephanie Price · page 72
- CBD Market
UK’s Quantum Farma to provide new cannabis treatments to Latin America
UK company Quantum Farma is working with FarmaUSA to launch two new cannabis treatments in the Latin American market.
- Medical
Panaxia agreement to bring medical cannabis products into Germany
The products are currently being used in Israel for oncology patients for cancer pain, loss of appetite and other side effects related to cancer treatments.
- CBD Market
Report explores cannabis regulations of North America and Europe
The first-of-its-kind report from New Frontier Data says that years of prohibition and an international illicit market have presented distinct challenges for legal markets.
- CBD Market
Peakbirch acquisition of Stul to accelerate cannabis sales to UK
Peakbirch Logic has acquired Stul Ltd and its ‘Hot Box Herb’ brand in a move that will accelerate its goal to expand cannabis sales to the UK.
- Medical
A new frontier in medicine: MGC Pharma discusses drug delivery innovation
MGC Pharma is hoping to bring more surprises to the market in the next few years.
- Companies
Tilray sees net revenue increase to $513m from last year
Tilray has a net income of $33.6m during the fourth quarter compared to net loss of $84.3m in the prior year quarter.
- Pharmaceutical
Oxford Cannabinoid Technologies secures drug development agreements
The agreements follow its post-IPO review after its £16.5m fundraise and admission to the main market on LSE in May this year.
- CBD Market
Paul Finnegan discusses 300 per cent growth of CBD brand Naturecan
CBD brand Naturecan has grown substantially over just a short period and seen record growth of 300 per cent over the last 12 months.
- Medical
Supply chains urged to use authentication to protect cannabis products
The IHMA says counterfeit cannabis is an alarming development that sees criminals taking advantage of people in desperate need of products.
- CBD Market
Sales surge puts Love Hemp on road to global expansion
Love Hemp expects further growth this year amid its launch on Amazon in Q1 2022, a new subscription model and overseas expansion in the US, Europe and Japan.
- CBD Market
Protest calls for farmers to ‘grow hemp without a licence’
Hempen is encouraging cultivators to grow hemp without a licence as applications can be refused for simple issues such as the farm being near a road or public footpath
- Medical
Patent for THC as Alzheimer’s treatment granted to India Globalization
India Globalization hopes the formula could provide relief for the potential 50 million people across the globe which are expected to be impacted by Alzheimer’s disease by 2030
